公众号 / 文章泌尿生殖腹部MR

前列腺癌经尿道超声消融的MRI规划与术后评估

Transurethral ultrasound ablation for prostate cancer: MRI-based pre-treatment planning and post-treatment assessment-what the radiologist needs to know.
PubMed 文献 · Abdom Radiol (NY) · 2026-07-01

本文基于超过100例病例的机构经验,系统回顾了MRI引导下经尿道超声消融(TULSA)治疗局限性前列腺癌的影像学流程。重点介绍多参数MRI在患者选择、治疗规划、术后即刻无灌注区评估及连续随访中的应用,并讨论炎症、血管改变、凝固性坏死和解剖变形等影像解读陷阱。

要点

  • 多参数MRI用于病灶定位、包膜外侵犯、精囊侵犯、关键前列腺周围结构及钙化评估。
  • 术后即刻增强MRI评估无灌注消融区,连续影像显示前列腺体积进行性缩小与组织重塑。
  • 炎症、血管改变、凝固性坏死和解剖变形可能掩盖或类似残留病灶。

核心结论

  • TULSA是MRI引导的热消融技术,可对局限性前列腺癌行局灶或全腺体消融,但长期肿瘤控制证据有限,尚不能视为根治性前列腺切除或放疗的等效方案。

研究设计与样本

  • 影像图谱式综述,基于超过100例TULSA病例的机构经验。
  • 未报告具体样本量统计、中心数、设备序列参数及参考标准细则。

关键影像表现/征象

  • 消融后即刻增强MRI显示无灌注消融区。
  • 连续随访影像表现为前列腺体积进行性缩小与组织重塑。
  • 治疗后炎症、血管改变、凝固性坏死和解剖变形可能掩盖或类似残留病灶。

诊断标准与关键数值

  • 多参数MRI评估内容包括病灶定位、包膜外侵犯、精囊侵犯、关键前列腺周围结构及可能影响超声传导的钙化。

临床应用与阅片要点

  • 放射科医师需理解TULSA的潜在作用及现有证据的局限性。
  • 阅片时需警惕炎症、血管改变、凝固性坏死和解剖变形对残留病灶判断的干扰。

局限性

  • TULSA的长期肿瘤控制临床数据仍然有限。
  • 本文为图谱式综述,未提供正式的诊断准确性指标或对照研究数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Transurethral ultrasound ablation (TULSA) is an MRI-guided thermal therapy that enables focal or whole-gland ablation of prostate tissue using real-time MR thermometry and feedback control. It is an emerging treatment option for carefully selected patients with localized prostate cancer, particularly when preservation of urinary and sexual function is an important clinical priority. However, TULSA is not yet an established equivalent to radical prostatectomy or radiation therapy, because available clinical data on long-term oncologic control remain limited. Radiologists should therefore understand both its potential role and the limitations of the current evidence. Multiparametric MRI plays a central role throughout the TULSA workflow, including lesion localization, assessment of extraprostatic extension and seminal vesicle invasion, evaluation of critical periprostatic structures, and identification of calcifications that may interfere with ultrasound transmission. Immediately after treatment, contrast-enhanced MRI is used to assess the non-perfused ablation zone, whereas serial imaging demonstrates progressive volume reduction and tissue remodeling. Interpretation may be challenging because inflammation, vascular changes, coagulative necrosis, and anatomical distortion can mimic or obscure residual disease. This pictorial essay provides a practical review of patient selection, treatment planning, post-treatment assessment, and imaging pitfalls after TULSA, based on institutional experience with more than 100 cases.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Takahashi, Miura, Higashiyama, et al. Transurethral ultrasound ablation for prostate cancer: MRI-based pre-treatment planning and post-treatment assessment-what the radiologist needs to know. Abdom Radiol (NY). 2026. PMID: 42380349. doi:10.1007/s00261-026-05642-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。